Search

Your search keyword '"Kerdraon, Olivier"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Kerdraon, Olivier" Remove constraint Author: "Kerdraon, Olivier"
199 results on '"Kerdraon, Olivier"'

Search Results

3. Pilot Feasibility Study: 18F-DPA-714 PET/CT Macrophage Imaging in Triple-Negative Breast Cancers (EITHICS).

5. The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

6. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment

13. Pilot study with [18F]DPA-714 PET-CT to explore tumor-associated-macrophages in triple negative breast cancer.

21. MALDI-MSI and Ovarian Cancer Biomarkers

24. Centre de Ressources Biologiques-Tumorothèque: Bioresources and Associated Clinical Data Dedicated to Translational Research in Oncology at the Institut de Cancérologie de l’Ouest, France

27. Additional file 18: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

28. Additional file 29: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

29. Additional file 5: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

30. Additional file 3: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

31. Additional file 4: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

32. Additional file 9: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

33. Additional file 6: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

34. Additional file 7: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

35. Additional file 8: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

37. Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

38. Significance of lymph node involvement in local recurrence of colorectal cancer

39. The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.

40. Abstract LB-142: CD94/NKG2A+ tumor-infiltrating lymphocytes in a context of HLA-E overexpression could be a promising new druggable inhibitory immune checkpoint in colorectal adenocarcinomas

41. Intraepithelial CD94+ tumor-infiltrating lymphocytes in a context of HLA-E overexpression as a new immune checkpoint to predict prognosis in colorectal carcinomas.

43. Scattering matrices in the sl(3) twisted Yangian

44. The inhibitory receptor CD94/NKG2A on CD8+tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

46. Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors – short text

Catalog

Books, media, physical & digital resources